Coping with COVID-19 in Patients with Lung Cancer

Click to increase image sizeClick to decrease image size

Conflicts of Interest

The authors have no conflicts of interest to disclose.

Ethics Approval

This study was approved by the University of Arizona’s Institutional Review Board (IRB No. 2004563860).

Additional information

Funding

This study received a basic/clinical partnership grant (Garland/Hamann) from the University of Arizona Cancer Center (P30CA023074).

Notes on contributors

Elizabeth S. Ver Hoeve

Elizabeth S. Ver Hoeve, MA, and Tara K. Torres, MA, are clinical psychology doctoral students, and Heidi A. Hamann, PhD, is an associate professor in the Department of Psychology at the University of Arizona, Tucson, Ariz.

Sarah N. Price

Sarah N. Price, PhD, is a postdoctoral fellow at Wake Forrest, Winston-Salem, N.C.

Tara K. Torres

Elizabeth S. Ver Hoeve, MA, and Tara K. Torres, MA, are clinical psychology doctoral students, and Heidi A. Hamann, PhD, is an associate professor in the Department of Psychology at the University of Arizona, Tucson, Ariz.

Heidi A. Hamann

Elizabeth S. Ver Hoeve, MA, and Tara K. Torres, MA, are clinical psychology doctoral students, and Heidi A. Hamann, PhD, is an associate professor in the Department of Psychology at the University of Arizona, Tucson, Ariz.

Linda L. Garland

Linda L. Garland, MD, is a thoracic medical oncologist and professor of medicine at the University of Arizona Cancer Center, Tucson, Ariz.